Real-World Data on Metastatic Lung Cancer: Cost Analyses in Brazil From a Private Insurance Company's Perspective
PURPOSENon–small cell lung cancer (NSCLC) is often diagnosed at late stages, leading to escalated treatment expenses. This study aimed to elucidate the costs of lung cancer treatment in a private health care setting in Brazil.MATERIALS AND METHODSWe conducted a retrospective cohort study, regarding...
Saved in:
| Main Authors: | Rodrigo Afonso da Silva Sardenberg, Mariana Ribeiro Monteiro, Cinthia Leite Frizzera Borges Bognar, Victor Braga Gondim Teixeira, Rodrigo de Carvalho Moreira, Henry Sznejder, Riad Naim Younes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society of Clinical Oncology
2025-04-01
|
| Series: | JCO Global Oncology |
| Online Access: | https://ascopubs.org/doi/10.1200/GO-24-00253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Costs of non-metastatic prostate cancer treatment among privately insured men in the United States
by: Ashley J. Housten, et al.
Published: (2025-01-01) -
Management of entrepreneurship of insurance agents and intrapreneurship in the insurance companies
by: E. G. Suleymanov
Published: (2020-01-01) -
Knowledge Management for Improved Digital Transformation in Insurance Companies: Systematic Review and Perspectives
by: Younes Elgargouh, et al.
Published: (2024-08-01) -
The Right of Insurant to Choose Medical Insurance Company in the Compulsory Health Insurance System
by: D. A. Storozhuk
Published: (2012-12-01) -
Social Responsibility for Insurance Companies
by: Milena Otavova, et al.
Published: (2023-04-01)